Skip to content
411 PRESS

DermaRite Industries Recalls

Assorted pharmaceutical pills and tablets — representative photo for FDA drug recall

An assortment of pharmaceutical pills (representative file photo). Specific recalled product: see recall details below. Photo: Michael Nutt / Wikimedia Commons (CC BY-SA 2.0).

Recalls in database
18
Agency
FDA
Years covered
2025

This hub covers 1 recall event involving DermaRite Industries, published by the FDA as 18 product-line records, 2025–2025. DermaRite makes skin- and wound-care products; the FDA issues one record per affected product line, so a single recall can appear as many records.

Each row links to the FDA enforcement record with the classification and the firm's corrective action.

18 recall records
Years 2025
Data through Aug 27, 2025

How this hub is built. This page collects 1 recall event tied to DermaRite Industries (across 18 product-line records) in the current 411 Press recall dataset. A note on counting. The three agencies package recalls differently. NHTSA issues one record per safety campaign; the CPSC issues one per recall; the FDA issues one per affected product line, so a single FDA recall can appear as dozens of records. Counting raw records would push FDA-heavy brands artificially to the top. The counts here are recall EVENTS — distinct agency events — with the FDA product-line record total shown alongside wherever the two differ. Records are grouped by a normalized version of the recalling firm's name (normalizer version 2026-07-28.C3.2). Parent, subsidiary, and "doing business as" relationships are not merged unless the agency data states them, so a corporate family can appear under more than one name. Regulator for these records: FDA. They were published 2025–2025. An event count reflects how much recall activity fell inside the current dataset — not a ranking of relative safety. Larger manufacturers and higher-volume product lines generate more recall activity. This is the current dataset, not an all-time total, and it grows as new notices are ingested. Every row links to the original agency notice.

2025 (18)

  • Class II

    UltraSure Anti-Perspirant & Deodorant, Aluminum Sesquichlorohydrate 15%, 118 mL

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    San-E-Foam, Alcohol 67%, 1000 mL

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    Renew Skin Repair Cream

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    Renew PeriProtect

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    PeriGuard Ointment

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    PeriGiene, Health Care Antiseptic, Chloroxylenol 0.5%, 222mL

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    McKesson Skin Protectant

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    Lantiseptic

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    Lantiseptic

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    KleenFoam Antimicrobial Foam Soap

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    Hand-E-Foam

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    GelRite Instant Hand Sanitizer

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    DermaSarra, Camphor 0.5%, External Analgesic, 222 mL

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    DermaMed Ointment, Skin Protectant, Aluminum Hydroxide Gel 2%, Net Wt

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    DermaKleen, Health Care Antiseptic Lotion Soap with Vitamin E, Chloroxylenol 0.2%, packaged in a) 222 mL

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    DermaFungal

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    DermaCerin

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

  • Class II

    4-N-1 Skin Protectant

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

Independent news on labor, safety, and accountability.